LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.4600
+0.0250 (5.75%)
At close: Mar 10, 2026
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 83.62 million as of March 11, 2026. Its market cap has decreased by -24.87% in one year.
Market Cap
83.62M
Enterprise Value
57.84M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.46
Market Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 83.62M, an increase of 57.83%. That is a compound annual growth rate of 22.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 83.62M | -36.06% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
| Dec 11, 2023 | 52.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 123.80M |
| Paradigm Biopharmaceuticals | 112.01M |
| Arovella Therapeutics | 92.95M |
| Cynata Therapeutics | 80.73M |
| Alterity Therapeutics | 76.13M |
| Imugene | 75.56M |
| Radiopharm Theranostics | 74.43M |
| Prescient Therapeutics | 63.09M |